Contrast media are used to enhance quality of medical imaging such as CT, MRI, PET/CT and ultrasound. Their value has long been recognized by radiologists and is well illustrated by their frequent use in radiology departments worldwide. Contrast media injectors (CMI) are devices employed for injecting contrast media into the body to improve the visibility of tissues for a medical imaging procedures.
Albany, NY -- (SBWIRE) -- 06/02/2016 -- Contrast media injectors are systems that inject contrast media into the body in order to enhance the quality of medical imaging procedures such as MRI, CT, ultrasound, and PET/CT. The rapid advancement in medical technology has allowed contrast media injectors to transform from manual to automated power injectors that are both safe and sophisticated. Contrast media injectors with pre-programmed multi-detector protocols are the latest trend in the market and cover basic medical requirements such as volume and rate of injection, contrast parameters, and type of organ being imaged.
The report studies the global contrast media injectors market on the basis of products and applications. By product, the market is segmented into MRI injectors, CT injectors, and angio/vascular injectors. In terms of application, the report analyzes three main uses: cardiology, neurology, and oncology.
Read Complete Report @ http://www.mrrse.com/contrast-media-injectors-market
With the help of the latest research and market intelligence tools, the report offers a 360-degree overview of the contrast media injectors market, together with strategic recommendations from industry experts.
Overview of the Contrast Media Injectors Market
The global market for contrast media injectors is primarily driven by the persistent rise in imaging procedures such as MRI and CT, which result in growing demand for efficient contrast media injectors. Increasing awareness regarding pre-diagnosis of disorders, leading to increased imaging procedures, has also fueled the growth of the contrast media injectors market.
In contrast, high cost of advanced technology and adverse reactions associated with contrast media injectors are likely to impede the development of the global market.
Inquiry on this report @ http://www.mrrse.com/enquiry/1395
Europe and North America lead the global contrast media injectors market and together account for a share of over 60% of the total market. Owing to the increasing prevalence of cardiovascular and neurological disorders in these two regions, North America and Europe are likely to retain their lead till the end of the forecast period. Asia Pacific, on the other hand, has exhibited immense potential for growth over the coming years, thanks to the development of medical tourism and the healthcare sector in countries such as China, India, and Australia.
As per the findings of the report, the global contrast media injectors market is projected to be worth US$886.7 million by 2020, growing at a 5.0% CAGR from a value of US$630.1 million in 2013.
Get a Free Sample Copy of the Report @ http://www.mrrse.com/sample/1395
Companies Mentioned in the Report
The vendor landscape of the contrast media injectors market is immensely consolidated in nature and a handful of established companies hold over 70% of the total market. The noteworthy players operating in the global contrast media injectors market are VIVID IMAGING Technologies, ulrich Medical GmbH & Co. KG, Medrad, Inc., Guerbet Group, Mallinckrodt Pharmaceuticals, Bracco Imaging S.p.A., Nemoto Kyorindo Co., Ltd., and MEDTRON AG.
MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.